Clinical trial
Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets
NCT00343278 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00343278 |
|---|---|
| Title | Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets |
| Official title | Post-Marketing Clinical Study of Valaciclovir Hydrochloride Tablets -Single Oral Dose Study in Hemodialysis Patients- |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Virus Diseases |
| Intervention type | Drug |
| Interventions | Valaciclovir Hydrochloride |
| Enrollment | 18 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jun 22, 2006 |
| Last update posted | Apr 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: